Coherus BioSciences, Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Coherus BioSciences, Inc. (CHRS) on August 11, 2021, covering events occurring on August 5, 2021. The filing addresses corporate governance changes rather than financial performance.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to Item 5.02 regarding officer departures and does not contain financial statements or operational metrics.
Material Changes
The material change reported is the resignation of Mary T. Szela from the Board of Directors, effective immediately on August 5, 2021. The Company explicitly states that the resignation was not the result of any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure regarding the director's departure.
Key Facts for Investors
- Mary T. Szela resigned from the Board of Directors effective August 5, 2021.
- The resignation was voluntary and not related to any disagreement with the Company.
- No financial data or operational updates are included in this specific filing.